These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7019772)

  • 1. [Electromyographic changes induced with oral supplements of carnitine in patients under regular periodical hemodialytic treatment].
    Albertazzi A; Spisni C; Del Rosso G; Gambi D; Rossini PM
    Minerva Nefrol; 1980; 27(4):647-9. PubMed ID: 7019772
    [No Abstract]   [Full Text] [Related]  

  • 2. Electromyographic changes induced by oral carnitine treatment in dialysis patients.
    Albertazzi A; Spisni C; Del Rosso G; Palmieri PF; Rossini PM
    Proc Clin Dial Transplant Forum; 1980; 10():1-6. PubMed ID: 7346837
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of carnitine administration in patients with chronic renal failure undergoing periodic dialysis, evaluated by computerized electromyography.
    Rocchi L; Feola I; Calvani M; D'Iddio S; Alfarone C; Frascarelli M
    Drugs Exp Clin Res; 1986; 12(8):707-11. PubMed ID: 3757765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Electromyographic and blood chemical changes in the transition from conservative therapy to short-term hemodialytic treatment. Preliminary data].
    Cambi V; Savazzi GM; Arisi L; Allegri L; Bignardi L; Mantovani GP; Rossi E
    Minerva Nefrol; 1975; 22(1):22-31. PubMed ID: 174032
    [No Abstract]   [Full Text] [Related]  

  • 5. [Short-term effect of treatment with oral DL-carnitine and intravenous L-carnitine in chronic uremia patients undergoing hemodialytic therapy].
    Demelia L; Solinas A; Gogoni G; Marongiu F; Besson A
    Recenti Prog Med; 1982 May; 72(5):664-74. PubMed ID: 6753066
    [No Abstract]   [Full Text] [Related]  

  • 6. Insulin action on glucose and protein metabolism during L-carnitine supplementation in maintenance haemodialysis patients.
    Biolo G; Stulle M; Bianco F; Mengozzi G; Barazzoni R; Vasile A; Panzetta G; Guarnieri G
    Nephrol Dial Transplant; 2008 Mar; 23(3):991-7. PubMed ID: 18045815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dialysis-related carnitine disorder.
    Hedayati SS
    Semin Dial; 2006; 19(4):323-8. PubMed ID: 16893411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of L-carnitine on insulin resistance in hemodialysed patients with chronic renal failure.
    Günal AI; Celiker H; Dönder E; Günal SY
    J Nephrol; 1999; 12(1):38-40. PubMed ID: 10203002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carnitine in metabolic disease: potential for pharmacological intervention.
    Arduini A; Bonomini M; Savica V; Amato A; Zammit V
    Pharmacol Ther; 2008 Nov; 120(2):149-56. PubMed ID: 18793670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin-resistant refractory renal anemia: effects of oral L-carnitine supplementation.
    Kawabata M; Kasuga S; Hara H; Suyama S; Moriyama K; Takabatake T
    Clin Nephrol; 2001 Mar; 55(3):265-6. PubMed ID: 11316253
    [No Abstract]   [Full Text] [Related]  

  • 11. L-carnitine in dialysed patients: the choice of dosage regimen.
    Berard E; Iordache A; Barrillon D; Bayle J
    Int J Clin Pharmacol Res; 1995; 15(3):127-33. PubMed ID: 8847154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carnitine in hemodialysis patients.
    Butler B
    Nephrol Nurse; 1983; 5(5):32-3. PubMed ID: 6557366
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of D-L carnitine on the metabolism of plasma lipids, copper and zinc in hemodialysis].
    Bustamante J; Martín Mateo MC; Bustamante R; San Segundo D
    Rev Clin Esp; 1983 Jan; 168(1):41-3. PubMed ID: 6844679
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of oral L-carnitine administration on insulin sensitivity and lipid profile in type 2 diabetes mellitus patients.
    González-Ortiz M; Hernández-González SO; Hernández-Salazar E; Martínez-Abundis E
    Ann Nutr Metab; 2008; 52(4):335-8. PubMed ID: 18714152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-carnitine supplementation in dialysis patients: does the evidence justify its use?
    Steinman TI
    Semin Dial; 2005; 18(1):1-2. PubMed ID: 15663752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of a multicenter study on the effect on serum triglycerides and cholesterol administration of carnitine in chronic uremia patients undergoing periodic hemodialysis treatment].
    Toigo G; Situlin R; Dardi F; Bazzato G; Vasile A; Tesio F; Ciman M; Guarnieri GF
    G Clin Med; 1982; 63(11-12):841-9. PubMed ID: 7182204
    [No Abstract]   [Full Text] [Related]  

  • 17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of carnitine supplementation on muscle metabolism by the use of magnetic resonance spectroscopy and near-infrared spectroscopy in end-stage renal disease.
    Vaux EC; Taylor DJ; Altmann P; Rajagopalan B; Graham K; Cooper R; Bonomo Y; Styles P
    Nephron Clin Pract; 2004; 97(2):c41-8. PubMed ID: 15218329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the effect of intravenous l-carnitine on quality of life in chronic hemodialysis patients.
    Semeniuk J; Shalansky KF; Taylor N; Jastrzebski J; Cameron EC
    Clin Nephrol; 2000 Dec; 54(6):470-7. PubMed ID: 11140808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind controlled trial of acetate versus bicarbonate dialysate.
    Uldall PR; Kennedy I; Craske H; Porrett E; Aid J; Woods F; Levine D
    Proc Clin Dial Transplant Forum; 1980; 10():220-3. PubMed ID: 7050983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.